At AMITA we had an early-stage solution for early outbreak management. It is based on the SARS commission report and the ability to manage information during that time, when there was an outbreak and nobody really knew what it was. People were concerned, some people died, and of course it really affected the economy at the time. This was a capability gap that we had a solution for, and that's the one we went forward with.
It is complex, in that it has to be integrated in the health system. Being able to test it with a federal department and then have some way of getting some other involvement from provinces and municipalities potentially becomes really interesting for us—being able to get it tested and really assess the effectiveness of it.
For example, it could be that there is a vessel of interest coming with refugees or something; or we have C. difficile outbreaks that are moving, and this has been recently reported. There are all kinds of things like that.
So that's the one we decided to submit under the program. It is in the early stage because it's not contracted, so the test is still yet to be done. The effectiveness will come after we see how this goes.
If I think back to our consular solution, we had to repackage it to sell it. Countries weren't interested in buying this whole, huge solution. They wanted to buy pieces of it depending on what they needed. So we also, as we're selling, have to change our business models. We have to think about what makes it more attractive to the buyer and that kind of thing. There are a lot of things going out throughout this product management cycle that you're talking about: about the product itself and where to go; what the best way to sell it is; what the best business model is to sell it in.
As time passes in the technology area.... You talked about the fact that this has a huge impact on us because we get new devices coming towards us. We get people using iPads in the hospital now. If we're not fast in getting this out the door, then we are always trying to retrofit the stuff into what we're doing.
I don't know whether that answers your question.